Rectosigmoid Cancer
5 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Physical Activity in Rectal Cancer Survivors (NCT06435975) | Abramson Cancer Center at Penn Medicine | 2022-06-01 |
| mFOLFOX6 vs. mFOLFOX6 + Aflibercept as Neoadjuvant Treatment in MRI-defined T3-rectal Cancer (NCT03043729) | AIO-Studien-gGmbH | 2017-03-06 |
| A Study Assessing Perfusion Outcomes With PINPOINT® Near Infrared Fluorescence Imaging in Low Anterior Resection (NCT02205307) | Novadaq Technologies ULC, now a part of Stryker | 2015-01-01 |
Track Rectosigmoid Cancer automatically
Every clearance here is in the API, with alerts when new ones post.